InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Goodman Noah. Insider active across 2 companies, notably Kymera Therapeutics, Inc.. Aggregated, 11 disclosures have been recorded. Split: 0 buy · 7 sells. Total volume traded: €871k. History available since 8 April 2025. The latest transaction was disclosed on 14 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Goodman Noah is Chief Business Officer at Kymera Therapeutics, Inc. The 11 filings on record, all within the sampled recent period from 2025-04-09 to 2026-06-25, show sales of EUR 870651 and no purchases.